HIV-1 genotypic resistance: automated sequence analysis and interpretation

Area of Science:

• Bioinformatics
• Molecular Biology
• Virology

Background:

• Antiretroviral therapy has led to the emergence of drug resistance in Human Immunodeficiency Virus type 1 (HIV-1).
• Accurate identification of resistance-related mutations is crucial for effective treatment strategies.
• Existing methods for mutation detection can be labor-intensive and require specialized expertise.

Purpose of the Study:

• To introduce GRANT (Genotypic Resistance Analysis Tool), a novel software for automated detection of HIV-1 resistance mutations.
• To provide commentary on the degree of drug resistance conferred by identified mutations.
• To develop a user-customizable tool adaptable for future discoveries and other organisms.

Main Methods:

• Development of a computational tool, GRANT, for analyzing HIV-1 protein sequences.
• Implementation of algorithms to identify known resistance-associated mutations.
• Integration of a customizable database for easy updates and organism adaptation.

Main Results:

• GRANT automatically detects resistance mutations in HIV-1 protein sequences.
• The tool provides an assessment of the level of resistance associated with detected mutations.
• The software is designed for user customization, allowing for updates and application to non-HIV organisms.

Conclusions:

• GRANT offers an automated and efficient method for identifying HIV-1 drug resistance mutations.
• The tool's customizability ensures its long-term utility in the evolving field of resistance monitoring.
• GRANT facilitates improved understanding and management of HIV treatment resistance.